Literature DB >> 26930406

Early HAART Initiation May Not Reduce Actual Reproduction Number and Prevalence of MSM Infection: Perspectives from Coupled within- and between-Host Modelling Studies of Chinese MSM Populations.

Xiaodan Sun1, Yanni Xiao1, Sanyi Tang2, Zhihang Peng3, Jianhong Wu4, Ning Wang5.   

Abstract

Having a thorough understanding of the infectivity of HIV, time of initiating treatment and emergence of drug resistant virus variants is crucial in mitigating HIV infection. There are many challenges to evaluating the long-term effect of the Highly Active Antiretroviral Therapy (HAART) on disease transmission at the population level. We proposed an individual based model by coupling within-host dynamics and between-host dynamics and conduct stochastic simulation in the group of men who have sex with men (MSM). The mean actual reproduction number is estimated to be 3.6320 (95% confidence interval: [3.46, 3.80]) for MSM group without treatment. Stochastic simulations show that given relatively high (low) level of drug efficacy after emergence of drug resistant variants, early initiation of treatment leads to a less (greater) actual reproduction number, lower (higher) prevalence and less (more) incidences, compared to late initiation of treatment. This implies early initiation of HAART may not always lower the actual reproduction number and prevalence of infection, depending on the level of treatment efficacy after emergence of drug resistant virus variants, frequency of high-risk behaviors and etc. This finding strongly suggests early initiation of HAART should be implemented with great care especially in the settings where the effective drugs are limited. Coupling within-host dynamics with between-host dynamics can provide critical information about impact of HAART on disease transmission and thus help to assist treatment strategy design and HIV/AIDS prevention and control.

Entities:  

Mesh:

Year:  2016        PMID: 26930406      PMCID: PMC4773120          DOI: 10.1371/journal.pone.0150513

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


  55 in total

1.  Adherence and drug resistance: predictions for therapy outcome.

Authors:  L M Wahl; M A Nowak
Journal:  Proc Biol Sci       Date:  2000-04-22       Impact factor: 5.349

2.  Life expectancy after HIV diagnosis based on national HIV surveillance data from 25 states, United States.

Authors:  Kathleen McDavid Harrison; Ruiguang Song; Xinjian Zhang
Journal:  J Acquir Immune Defic Syndr       Date:  2010-01       Impact factor: 3.731

3.  Bioethical challenges with HIV treatment as prevention.

Authors:  Jeremy Sugarman
Journal:  Clin Infect Dis       Date:  2014-07       Impact factor: 9.079

Review 4.  Attaining higher goals in HIV treatment: the central importance of adherence.

Authors:  G H Friedland; A Williams
Journal:  AIDS       Date:  1999-09       Impact factor: 4.177

5.  Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group.

Authors:  T C Quinn; M J Wawer; N Sewankambo; D Serwadda; C Li; F Wabwire-Mangen; M O Meehan; T Lutalo; R H Gray
Journal:  N Engl J Med       Date:  2000-03-30       Impact factor: 91.245

6.  Life expectancy of persons receiving combination antiretroviral therapy in low-income countries: a cohort analysis from Uganda.

Authors:  Edward J Mills; Celestin Bakanda; Josephine Birungi; Keith Chan; Nathan Ford; Curtis L Cooper; Jean B Nachega; Mark Dybul; Robert S Hogg
Journal:  Ann Intern Med       Date:  2011-07-18       Impact factor: 25.391

7.  Prevention of HIV-1 infection with early antiretroviral therapy.

Authors:  Myron S Cohen; Ying Q Chen; Marybeth McCauley; Theresa Gamble; Mina C Hosseinipour; Nagalingeswaran Kumarasamy; James G Hakim; Johnstone Kumwenda; Beatriz Grinsztejn; Jose H S Pilotto; Sheela V Godbole; Sanjay Mehendale; Suwat Chariyalertsak; Breno R Santos; Kenneth H Mayer; Irving F Hoffman; Susan H Eshleman; Estelle Piwowar-Manning; Lei Wang; Joseph Makhema; Lisa A Mills; Guy de Bruyn; Ian Sanne; Joseph Eron; Joel Gallant; Diane Havlir; Susan Swindells; Heather Ribaudo; Vanessa Elharrar; David Burns; Taha E Taha; Karin Nielsen-Saines; David Celentano; Max Essex; Thomas R Fleming
Journal:  N Engl J Med       Date:  2011-07-18       Impact factor: 91.245

8.  [HIV infection and KAP status among men who have sex with men in 14 Chinese cities].

Authors:  Yu-gang Bao; Yan-hui Zhang; Jin-kou Zhao; Jiang-ping Sun; Hong-zhuan Tan
Journal:  Zhonghua Yu Fang Yi Xue Za Zhi       Date:  2009-11

9.  Correcting the actual reproduction number: a simple method to estimate R(0) from early epidemic growth data.

Authors:  Hiroshi Nishiura
Journal:  Int J Environ Res Public Health       Date:  2010-01-21       Impact factor: 3.390

Review 10.  Modeling antiretroviral drug responses for HIV-1 infected patients using differential equation models.

Authors:  Yanni Xiao; Hongyu Miao; Sanyi Tang; Hulin Wu
Journal:  Adv Drug Deliv Rev       Date:  2013-04-17       Impact factor: 15.470

View more
  4 in total

1.  Expanded antiretroviral treatment, sexual networks, and condom use: Treatment as prevention unlikely to succeed without partner reduction among men who have sex with men in China.

Authors:  Jie Lou; Peipei Hu; Han-Zhu Qian; Yuhua Ruan; Zhen Jin; Hui Xing; Yiming Shao; Sten H Vermund
Journal:  PLoS One       Date:  2017-04-13       Impact factor: 3.240

2.  Multi-scale immunoepidemiological modeling of within-host and between-host HIV dynamics: systematic review of mathematical models.

Authors:  Nargesalsadat Dorratoltaj; Ryan Nikin-Beers; Stanca M Ciupe; Stephen G Eubank; Kaja M Abbas
Journal:  PeerJ       Date:  2017-09-28       Impact factor: 2.984

3.  Coupling the Macroscale to the Microscale in a Spatiotemporal Context to Examine Effects of Spatial Diffusion on Disease Transmission.

Authors:  Yanni Xiao; Changcheng Xiang; Robert A Cheke; Sanyi Tang
Journal:  Bull Math Biol       Date:  2020-05-10       Impact factor: 1.758

4.  Comparison of two simulators for individual based models in HIV epidemiology in a population with HSV 2 in Yaoundé (Cameroon).

Authors:  Diana M Hendrickx; João Dinis Sousa; Pieter J K Libin; Wim Delva; Jori Liesenborgs; Niel Hens; Viktor Müller; Anne-Mieke Vandamme
Journal:  Sci Rep       Date:  2021-07-19       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.